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ABSTRACT  
The main aim of this study to determine the explanatory 
variables of the Chinese exports of COVID-19 medical 
supplies to its 89 major trading partners in the first half of the 
year 2020. In addition, it explores the puzzle of COVID-19 
pandemic outbreak from an economic perspective. We used 
the Ordinary-least-square (OLS) regression under a cross-
sectional data framework to construct the quantitative 
analysis.  
The main findings are: First, the number of old population 
and the number of COVID-19 confirmed cases in the trading 
partner have been drivers of Chinese exports of COVID-19 
medical supplies. Second, tariff barriers levied on the trading 
partner significantly impedes the Chinese exports of COVID-
19 medical supplies to its trade partners, especially from 
middle-income countries. 
In future work, the analysis of this type of trade through 
the supply-side factors could be investigated. Also, some other 
variables such as non-tariff measures could be utilized. The 
study encourages literature for empirically analyzing the trade 
of medical supplies, in general, under econometric modeling. 
The results are illustrated based on consistent quantitative 
evidence. 
JEL Codes: F140, F190, I150, O190, F400, F490.  
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I. INTRODUCTION 
On March 11, 2020, the World Health Organization 
(WHO), categorized the COVID-19 outbreak as a global 
pandemic. Since the number of confirmed cases increased to 
more than 118 thousand, and about 4,291 deaths. Also, 
COVID-19 was spread in more than 114 countries and regions 
around the world. By the end of June 2020, WHO, (2020) 
announced the number of confirmed cases worldwide has 
become more than 10 million and about 500 thousand deaths 
and has spread to 216 countries and regions in the world. In 
addition, USA is ranked to be number one at total confirmed 
cases with more than 2.5 million and also for death number 
with more than 126 thousand.   
Furthermore, Kose, Sugawara, & Terrones (2020) 
clarified that the world economy faced four major global 
recessions since 1950 specifically in 1975, 1982, 1991, and 
2009. These four global recessions are determined based on 
the following variables: the sharp decline in annual real global 
per capita GDP, world industrial production trends, world 
trade changes, the world investment flows, world oil 
consumption levels, and world employment directions. 
Likewise, the World Bank (2020) stated that COVID-19 is 
the greatest recession in history since 1871 with an annual 
contraction in per capita GDP by 92.9%, in comparison to the 
previously mentioned recessions in 1975, 1982, 1991, and 
2009 which are equal to 39.4%, 44.6%, 46.8%, and 61.2% 
respectively. Also, the great depression era lasting from 1929 
to 1939 was ranked as the maximum annual contraction in per 
capita GDP- mainly in the year 1931- by 83.8%, recently is 
ranked as number two in the history since 1871, while 
COVID-19 is ranked as number one. 
Clearly, the main question appears now, how the COVID-
19 outbreak pandemic affect the world economy? both 
Carlsson-Szlezak, Reeves , & Swartz (2020) and 
Maliszewska, Mattoo, & van der Mensbrugghe (2020) 
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answered this question by the following interconnected 
windows:  
• The first is the structure of the household spending, 
where there was a contraction of consumption from 
unnecessary products due to the social distancing 
measures. Baker, Farrokhnia, Meyer, Pagel, & 
Yannelis (2020) analyzed this window in USA and 
found that after March 10, 2020, there is a sharp fall in 
household spending by approximately 50%, with raise 
levels of spending on grocery products followed by a 
sharp drop. This result is consistent with another 
survey that found a 35% fall in total household 
spending at the same period. 
• The second one is the financial market window, which 
links between the financial market shocks and the real 
economy. Albulescu (2020) examined the impact of 
COVID-19 on the financial volatility based on S&P 
500 index as a proxy for the US financial markets’ 
volatility; and he found that the new confirmed cases 
reported at global level and in the US expand the 
financial volatility, in addition, the fatality rate has a 
positive and significant impact on the financial market 
volatility. 
• The third is the production window where COVID-19 
keeps some factories locked down, it inversely 
impacted both employment and supply chains. For 
employment, Bell & Blanchflower (2020) estimated 
the US unemployment rate in April 2020 by about 
20%. On the other hand, for supply chains, Gereffi 
(2020) indicated that there is an imbalance between the 
governmental official strategy and the strategies of 
major multinational suppliers of face masks in USA, 
which resulted in a negative impact on health 
outcomes. Also, the U.S. shortage in some COVID-19 
medical supplies such as N95 respirators is due to this 
imbalance. 
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• The fourth is the window of global trade and foreign 
direct investment (FDI). For the global trade, 
Maliszewska, Mattoo, & van der Mensbrugghe 
(2020) argued that COVID19 outbreak pandemic 
raises the international trade costs by 25% due to 
higher international transportation costs, additional 
inspections measures, foreign trade restrictions, etc. 
which has a negative impact in the global trade 
volume. For instance, according to International trade 
center data1, the US total trade shrank from USD 2 
trillion in the first half of the year 2019 to USD 1.79 
trillion in the first half of the year 2020. For FDI, 
according to World Investment Report (2020), the 
forecasting of FDI volume in 2020 will be lower than 
USD 1 trillion for the first time since the year 2005. In 
addition, FDI will fall around 40% in 2020 compared 
with 2019.  
 
Healthcare products, in general, are widely extended in 
several Chapters of the Harmonized System (HS) 
classification. Indeed, both The World Customs Organization 
(WCO) and the World Health Organization (WHO) classified 
the Covid-19 medical supplies into eight groups with fifty-
three products. This classification is based on the HS 2017. 
These groups are the following2: 
i. COVID-19 Test kits/ Instruments and apparatus used 
in Diagnostic Testing, e.g., COVID-19 Test kits.   
ii. Protective garments and the like, e.g., Gloves. 
iii. Disinfectants and sterilization products for example 
Alcohol solution etc.  
iv. Oxygen Therapy equipment and pulse oximeters, e.g., 
Medical ventilators (artificial respiration apparatus).  
v. Other medical devices and equipment, e.g., 
Stethoscopes. 
 
1 https://www.trademap.org/Index.aspx 
2 http://www.wcoomd.org/en/media/newsroom/2020/april/joint-wco-who-hs-
classification-list-for-covid_19-medical-supplies-issued.aspx  
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vi. Other Medical Consumables, e.g., Soap. 
vii. Vehicles, e.g., Ambulances.  
viii. Other products, e.g., Medical or surgical furniture. 
 
This paper relates to two types of literature. The first is 
research on the COVID-19 puzzle. However, both theoretical 
and practical works on this puzzle have discussed only from 
purely medical view e.g., Konieczny & Roterman (2020) and 
Ikizler (2020). However, some of this literature might be 
useful form an economic perspective, for instance, Rochon, 
Wei, Vasily & Nathan  (2020) mentioned that mortality rates 
had higher in case of older people. Therefore, this finding was 
employed in our constructed econometric model. 
Second, there is a rare literature focused on the global 
trade of medical supplies. Namely, Vickers & Salamat (2020) 
mapped the medical supply chains and analyzed the top 
exporters and importers of key medical products and assessed 
the potential impact of recent trade measures  in less developed 
countries (LDCs), and found that both global support and 
collaboration have a significant role to boost the healthcare 
systems in LDCs. 
As well as, Evenett (2020) investigated the recent trade 
policy stance towards the imported products used by 
healthcare sector to deal with COVID-19, and found that  as 
of the end of March 2020, a total of 54 countries have applied 
some type of export restraints on COVID-19 medical supplies 
and medicines. As a result, the prices raised, and deficit 
created by export curbs which leads to a limit or deny 
consumers access to COVID-19 medical supplies and 
medicines. 
Likewise, Mikic, T, & James (2020) examined the trade 
impacts of COVID-19 as one of the foreign shocks on the 
healthcare sector. They found that before COVID-19 time, 
there was a rise in the tariff rates levied on several 
pharmaceutical ingredients due to the trade war between China 
and the USA. Moreover, the temporary economies lockdown 
as a response to COVID-19 led to instant short-term confusion 
in the production and trade of key medical products. Also, they 
6  
indicated to the deleterious effects of trade barriers on 
healthcare products. institutionally, WTO (2020) mentioned 
that tariff rates levied on some medical products remain very 
high. e.g., although, the applied tariff rate for hand soap is 17% 
some countries levy tariffs as high as 65%. Also, OECD 
(2020) claimed that there is an incomplete specialization in 
both production and exports of COVID-19 medical supplies. 
Therefore, no single producer supplies efficiently all the 
required medical products to meet COVID-19.  
Finally, the research question can be formulated as "how 
global trade of medical supplies can solve the COVID-19 
puzzle?", To investigate this question, firstly, we analyze the 
pattern for this type of trade, specifically in the first half of the 
year 2020 (section II). Secondly, we construct an econometric 
model to determine the explanatory variables for the Chinese 
exports of COVID-19 medical supplies (section III). Finally, 
we summarize the main findings that can help researchers to 
find the missing piece of the COVID‐19 puzzle from the 
economic perspective (section IV). 
 
II. PATTERN OF TRADE IN COVID-19 MEDICAL 
SUPPLIES  
According to the International trade center (ITC), exports 
of COVID-19 medical supplies constitute a relatively small 
proportion of total products exports, and this ratio has stable 
between 3% to 4% during the period from 2001 to 2019. In 
contrast, trade of COVID-19 medical supplies grown a 6% 
share of total trade in the first half of 2020. 
Figure (1) plot the trade relative growth rates (TRGR), 
which show two different times of growth. First, prior to 
COVID-19 pandemic, the two rates of growth moved in the 
same direction with different values. Second, in the period of 
COVID-19, the two rates of growth moved in the opposite 
direction with a wide gap. 
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TRGR was calculated by the following formula (value in time B – value in time A)/ value in 
time A.  
 
FIGURE (1) 
Trade relative growth rates (TRGR) 
 
Globally, table (1) displays the ten leading exporters of 
COVID-19 medical supplies. Hence, it is possible to indicate 
that the monopoly degree has increased in the global market 
of COVID-19 medical supplies. This finding noted due to two 
reasons. First, there is a rise in the concentration ratio for the 
world export of COVID-19 medical supplies, Where, the top 
10 exporters account for around 72% of the world exports in 
the year 2019. This ratio expands to 79% of the world exports 
in the first half of the year 2020. Second, in a comparison 
between the year 2019 and the COVID-19 time, it's clear that 
there is no change in the countries list but only changes in the 
rank.  
Obviously, China has gained from the COVID-19 
outbreak pandemic by doubled its share by more than twice 
from the global exports of COVID-19 medical supplies. 
Currently, China replaced Germany's position as the top 
exporter of COVID-19 medical supplies compared with the 
fifth rank of China in the year 2019.    
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TABLE (1) 
TOP TEN EXPORTERS OF COVID-19 MEDICAL SUPPLIES 
US$ thousands 
The year 2019 The 1st half of the year 2020 
Exporter Value *Share % Exporter Value *Share % 
Germany 108464175 14 China 61967962 16 
USA 90551085 12 Germany 55410875 14 
Switzerland 77985202 10 USA 44189908 11 
Netherlands 54667095 7 Switzerland 42440524 11 
China 54237673 7 Netherlands 24134193 6 
Belgium 44008858 6 Ireland 23321686 6 
Ireland 42528652 5 Belgium 21272396 5 
Italy 34052804 4 France 15634960 4 
France 30704469 4 Italy 14464409 4 
UK 27296188 3 UK 13613021 3 
Total* 564496201 72 Total* 316449934 79 
The world 786481124 The world 398492883 
*calculated by the author  
Source: ITC calculations based on UN COMTRADE and ITC statistics 
 
On the other hand, table (2) summarizes the list of ten 
leading importers of COVID-19 medical supplies. Generally, 
in the year 2019, the whole list dominated about 61% of global 
imports against 70% in the COVID-19 time. As the leading 
exporter list, there is no change in the leading importer list but 
only changes in the rank. In fact, the United States kept its rank 
as the first importer of COVID-19 medical supplies and 
increased its global share from 19% to 24% in 2019 and the 
COVID-19 period respectively. For China, the value of its 
imports decreased more than twice in the COVID-19 time 
compared with before the COVID-19 time.  
   
TABLE (2) 
TOP TEN IMPORTERS OF COVID-19 MEDICAL SUPPLIES 
US$ thousands 
The year 2019 The 1st half of the year 2020 
Importer Value 
*Share 
% 
Importer Value 
*Share 
% 
USA 153235555 19 USA 91508185 24 
Germany 68029800 8 Germany 40873103 6 
China 44271037 5 Japan 22489460 5 
Netherlands 39164468 5 France 20426111 4 
Belgium 38310286 5 Belgium 18360407 4 
Japan 37031649 5 Switzerland 16700303 2 
France 31008062 4 Netherlands 16600297 2 
UK 28631023 4 UK 15872864 1 
Italy 27567010 3 China 15633149 1 
Switzerland 25381906 3 Italy 12659248 1 
Total* 492630796 61 Total* 271123127 70 
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The world 805353306 The world 387933802 
*calculated by the author  
Source: ITC calculations based on UN COMTRADE and ITC statistics 
 
At the product level with the latest available data, the 
global trade of COVID 19 medical supplies is highly 
concentrated: only two products namely Hydrogen peroxide 
presented as a medicament and COVID-19 Test kits account 
together for half of the world exports while the top five 
products account for 72% as the table (3) shows.   
TABLE 3 
TOP FIVE TRADED PRODUCTS OF COVID-19 MEDICAL SUPPLIES IN THE 
YEAR 2019 
US$ thousands 
Product Value 
Share 
%* 
leading 
exporter 
leading 
importer 
Hydrogen peroxide presented as a 
medicament 
297514738 38 Germany USA 
COVID-19 Test kits 114029575 14 Switzerland USA 
Plastic face shields (covering more 
than the eye area) 
64691603 8 China USA 
Extracorporeal membrane 
oxygenation (ECMO) 
58473386 7 USA USA 
Needles (except for tubular metal 
needles and needles for sutures), 
catheters, cannulae and the like 
33301007 4 
USA USA 
Total* 568010309 72 
*calculated by the author  
Source: ITC calculations based on UN COMTRADE and ITC statistics 
 
According to ITC data, there are some analytical notes can 
help to understand the trade gains of China due to COVID-19 
as follow:  
a. The surplus of Chinees trade balance of COVID-19 
medical supplies grew by more than nine times in the 
second quarter of 2020 in a comparison with prior to 
the year 2020.  
b. Both April and July in the year 2020 recorded the 
highest monthly surplus of the Chinees trade balance 
value.    
c. Over two past decades, the Chinees trade balance of 
services recorded the lowest shortage level in the first 
quarter of the year 2020. 
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Clearly, both previous analysis and interpretation agree 
with the clarification of Torrey (2018), Eriksen (2020), and 
Di Tommaso (2020) through three justifications. First, the 
priority degree of the healthcare sector and related industries 
under the plan of “Made in China 2025”, and how to adjust the 
structure of the global healthcare market as a Chinese goal. As 
mentioned before, we can claim that this goal has started to 
achieve by raising the China export share of COVID-19 
medical supplies from 7% to 16% in the year 2019 and in the 
first half of 2020, respectively. Second, the position of China 
as the leading supplier of inputs using in the production of 
medicines. Numerically, more than 80% of the medicines' 
ingredients worldwide are made in China. This finding 
explains the short time for China to develop vaccines for 
protection against COVID-19, under a large global 
competition between the leading economies.  
Third, the story of the Chinese new growth model that 
depends on innovation, and its impact on the healthcare 
industries. Here, it's possible to talk about a new concept of 
innovation which is disruptive innovation. this concept was 
discussed by Wan, Williamson, & Yin (2015) who 
highlighted that China is the Key supplier of disruptive 
innovation. Hence, we claim that the COVID-19 may be 
classified as a form of disruptive innovation to achieve the 
Chines economic goals in both the medium and long run.  
 
III. THE ECONOMETRIC MODEL 
One of the core issues of the COVID-19 pandemic is the 
global trade of medical supplies. Until the year 2019, the 
leading framework for understanding the explanatory 
variables of this type of trade is the supply-side theories. For 
example, Heckscher–Ohlin - Samuelson theorem which 
depend on both the cost and factor endowment with neglecting 
the demand side variables. Recently, the demand side 
emerging to select adequate explanatory variables of global 
trade in COVID-19 medical supplies. the last is our started 
point in the following econometric model.  
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A. MODEL SPECIFICATION 
In this context, we will determine the relationship 
between Chines exports of COVID-19 medical supplies 
(CHEX) as a dependent variable and the following 
independent variables in the imported partner of China for this 
type of exports: 
1. The number of population 65 years and more 
(OPOP),  
2. The stock of COVID-19 confirmed cases (CASE), 
3. The average applied imported tariff rate for these 
products (TARF).   
     
All the variables – except TARF- are changed into 
logarithms. As result, the model occurred in linear functional 
form as follows: 
 
Log (CHEX) = α0 + α1 Log (OPOP) + α2 Log (CASE) + α3 TARF 
 
B. METHOD, PERIOD AND DATA 
To estimate the above model in China, we will employ 
cross-sectional data and ordinary least square (OLS) method. 
Therefore, our appropriate point of time was the first half of 
the year 2020. In addition, our sample consists of 89 importing 
partners for Chines COVID-19 medical supplies. This sample 
categorized into two groups based on the World Bank 
classification of countries3. So, the first group is high-income 
partners and involves 44 members. And the second group is 
middle-income partners and involves 45 members. Finally, the 
full illustration of variables stated in Table (4). 
 
TABLE 4 
DESCRIPTION OF VARIABLES  
Variable  Description Source 
CHEX 
Value of Chinese exports of COVID-19 medical 
supplies to the partner (Thousands of USD) 
ITC, Trade maps 
OPOP The number of population 65 years and more The World Bank 
CASE The stock of COVID-19 confirmed cases WHO 
TARF 
The average applied imported tariff rate for 
COVID-19 medical supplies  
WTO 
 
3 The list of countries available in the appendix  
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C. ESTIMATION AND INTERPRETATION 
 
Table (5) presents the results of estimated models of 
Chines exports of COVID-19 medical supplies and its 
partners, where model number one related to the full sample, 
while model number two related to the high-income partners. 
Finally, model number three related to Middle-income 
partners. The estimated models can be interpreted as follow:  
a. There is a significant positive relationship between the 
number of old population 65 years and more from one 
side, and the chines exports of covid-19 medical 
supplies from the other side. In detailed words, based 
on the estimated coefficients, a one percent increase in 
the number of old population 65 years and more 
worldwide, this will yield a range from 0.44 percent to 
0.60 percent increase in the Chines exports of covid-19 
medical supplies.  
b. Similarly, there is a significant positive relationship 
between the number of COVID-19 confirmed cases 
from one side, and the chines exports of COVID-19 
medical supplies from the other side. In detailed words, 
based on the estimated coefficients, a one percent 
increase in the COVID-19 confirmed cases worldwide, 
will yield a range from 0.12 percent to 0.38 percent 
increase in the Chines exports of COVID-19 medical 
supplies. In the nonlinear estimated models, an 
increase in a new confirmed case of COVID-19 by one 
individual worldwide leads to an increase in the 
Chinese exports of COVID-19 medical supplies by 
5702 USD and 825 USD in the case of high-income 
and middle-income countries respectively.    
c. On the contrary, For the tariff barriers, in case of full 
sample, a one percent increase in the applied tariff rate 
on the world imports of covid-19 medical supplies will 
lead to an 0.18 percent cut of the Chines exports of 
covid-19 medical supplies. On the contrary, this 
relationship misses its significance completely in the 
case of high-income partners.   
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d. Based on the values of both R2 and Adj.R2, the 
independent variables explain a range from 66% to 
80% of the Chinese exports of COVID-19 medical 
supplies. 
e. The value of Durbin – Watson stat around two which 
means no serial correlation.   
 
TABLE 5 
ESTIMATED MODELS  
Independent variables  1 2 3 
C 3.39 
(4.09) 
2.74 
(3.07) 
1.87 
(1.59) 
Log (OPOP) 0.44 
(6.7) 
0.45 
(6.46) 
0.60 
(6.16) 
Log (CASE) 0.30 
(6.27) 
0.38 
(5.82) 
0.12 
(2.25) 
TARF - 0.18 
(-5.68) 
- 0.08 
(-0.9) 
- 0.05 
(-1.73) 
R2 0.67 0.80 0.69 
Adj. R2 0.66 0.78 0.67 
Durbin – Watson stat 2.01 1.73 2 
Number of observations  89 44 45 
Note: ( ) denotes value of t statistic.  
D. DIAGNOSTICS TESTS 
Actually, Baltagi (2005) clarified that cross-sectional 
studies are plagued with two popular econometric problems. 
First, Heteroskedasticity where the sample units may be of 
widely different sizes which may lead to appear different 
variation. Second, Multicollinearity when there is a significant 
relationship between independent variables. According to the 
prior problems, Table (6) shows the appropriate conducted 
diagnostic tests. For the Heteroskedasticity problem, we 
applied the Breusch-Pagan-Godfrey test and the result is we 
accept the null hypothesis because the Probability Chi-Square 
is greater than 5 percent which means the homogeneity of 
variance or and the same scatter of data.  
As well as, for the multicollinearity problem, Gujarati 
(2003) suggested a benchmark that if the value of centered 
variance inflation factor above ten this leads to 
multicollinearity. Clearly, the estimated Centered Variance 
Inflation Factors (VIF) for the three models meet this 
condition. 
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TABLE 6 
ESTIMATED MODELS  
Diagnostic tests 1 2 3 
 
Breusch-Pagan-Godfrey test 
Prob. F(3,40) 0.738 0.543 0.360 
Prob. Chi-Square(3) 0.728 0.519 0.340 
Variance Inflation Factors 
Centered VIF 
Log (OPOP) 1.37 1.41 1.70 
Log (CASE) 1.32 1.45 1.60 
TARF 1.04 1.15 1.12 
 
IV. CONCLUSION 
The global trade of medical supplies, in general, could be 
used as an answer for the puzzle of the COVID-19 pandemic 
outbreak. Although China is the country of origin for the 
COVID-19 virus it was the major winner compared with the 
rest of the world, this is the puzzle where our study tried to 
solve it form the economic perspective.  
We constructed an econometric model of COVID-19 for 
China and 89 major trade partners. We used new appropriate 
variables to investigate the relationship of Chines exports of 
COVID-19 medical supplies to the old population, the number 
of COVID-19 confirmed cases and tariff barriers.  
Our findings are consistent with models that investigated 
the significant role of export demand in the importing partner. 
The results suggested that the export opportunities of COVID-
19 medical supplies more profitable in the case of high-income 
importing countries compared with middle-income importing 
countries. For instance, an increase in a new confirmed case of 
COVID-19 by one individual worldwide leads to an increase 
in the Chinese exports of COVID-19 medical supplies by 5702 
USD and 825 USD in the case of high-income and middle-
income countries respectively.    
Further understanding of the global trade, in general, and 
medical supplies especially will be important to understand the 
Chinese role in the modern economic order in the middle-run 
under the plan of “Made in China 2025” and in the long-run 
through the initiative of One Belt and One Road.        
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